Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -153,610 | -650,175 | 377,661 | -348,865 | 66,858 |
| Depreciation Amortization | 19,837 | 24,172 | 17,953 | 11,041 | 4,725 |
| Accounts receivable | -200,000 | 305 | -161 | -45 | -11 |
| Other Working Capital | -193,585 | 19,845 | 26,859 | 33,440 | -48,430 |
| Other Operating Activity | 266,983 | 110,112 | 116,660 | 66,063 | 33,535 |
| Operating Cash Flow | $-260,375 | $-495,741 | $538,972 | $-238,366 | $56,677 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 386,617 | -221,467 | -953,725 | -522,812 | N/A |
| PPE Investments | -9,470 | -37,188 | -81,705 | -18,358 | -6,684 |
| Other Investing Activity | -2,500 | 0 | 0 | 0 | 8,009 |
| Investing Cash Flow | $374,647 | $-258,655 | $-1,035,430 | $-541,170 | $1,325 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 62,664 | 38,592 | 250,945 | 1,016,152 | 430,983 |
| Financing Cash Flow | $62,664 | $38,592 | $250,945 | $1,016,152 | $430,983 |
| Exchange Rate Effect | 73 | -80 | -11 | 40 | 15 |
| Beginning Cash Position | 224,060 | 939,944 | 1,185,468 | 948,812 | 459,812 |
| End Cash Position | 401,068 | 224,060 | 939,944 | 1,185,468 | 948,812 |
| Net Cash Flow | $177,009 | $-715,884 | $-245,524 | $236,656 | $489,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -260,375 | -495,741 | 538,972 | -238,366 | 56,677 |
| Capital Expenditure | -9,470 | -37,188 | -81,705 | -18,358 | -6,684 |
| Free Cash Flow | -269,845 | -532,929 | 457,267 | -256,724 | 49,993 |